Why the Thai HIV Vax Trial Worked

New molecular analyses yield clues to the success of a 2009 human HIV vaccine study.

By | September 19, 2011

Vaccine administrationWIKIMEDIA, US GOVERNMENT

The immunoglobulin G (IgG) antibody was key to the first-ever successful HIV vaccine trial in humans, reported researchers following up on the study's results.

In 2009, trial organizers announced that the particular vaccine combination used made people who received it 30 percent less likely to contract HIV than those who got a placebo. Since then, researchers have been pouring over blood samples from participants, hoping to determine the keys to the vaccine's marginal success where so many others have failed. Last week’s announcement marks one of the first answers to that question: individuals with the IgG antibody, which recognizes a specific part of HIV's envelope, were 43 percent less likely to contract the virus.

Knowing more about why the vaccine lent some protection against the virus may inform future efforts to create even more effective shots, perhaps targeting IgG production as a central strategy. "What we now have are clues as to why it might have worked," study leader researcher Barton Haynes of the Duke Human Vaccine Institute said at the press conference last week. "That's something we haven't had over the past 30 years. That's very important for the field."

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Comments

Avatar of: Rich

Anonymous

September 19, 2011

Pouring over?

Avatar of: TheSciAdmin

TheSciAdmin

Posts: 56

September 19, 2011

Good catch, Rich. Thanks for poring over this story. The mistake you noted has been corrected.

Avatar of:

Posts: 0

September 19, 2011

Pouring over?

Avatar of:

Posts: 0

September 19, 2011

Pouring over?

Avatar of:

Posts: 0

September 19, 2011

Good catch, Rich. Thanks for poring over this story. The mistake you noted has been corrected.

Avatar of:

Posts: 0

September 19, 2011

Good catch, Rich. Thanks for poring over this story. The mistake you noted has been corrected.

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. What Budget Cuts Might Mean for US Science
    News Analysis What Budget Cuts Might Mean for US Science

    A look at the historical effects of downsized research funding suggests that the Trump administration’s proposed budget could hit early-career scientists the hardest.  

  3. Opinion: On “The Impact Factor Fallacy”
  4. Unstructured Proteins Help Tardigrades Survive Desiccation
Business Birmingham